Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 8/2016

27.05.2016 | Original Article

Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories

verfasst von: N. Wurtz, A. Papa, M. Hukic, A. Di Caro, I. Leparc-Goffart, E. Leroy, M. P. Landini, Z. Sekeyova, J. S. Dumler, D. Bădescu, N. Busquets, A. Calistri, C. Parolin, G. Palù, I. Christova, M. Maurin, B. La Scola, D. Raoult

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Laboratory-acquired infections due to a variety of bacteria, viruses, parasites, and fungi have been described over the last century, and laboratory workers are at risk of exposure to these infectious agents. However, reporting laboratory-associated infections has been largely voluntary, and there is no way to determine the real number of people involved or to know the precise risks for workers. In this study, an international survey based on volunteering was conducted in biosafety level 3 and 4 laboratories to determine the number of laboratory-acquired infections and the possible underlying causes of these contaminations. The analysis of the survey reveals that laboratory-acquired infections have been infrequent and even rare in recent years, and human errors represent a very high percentage of the cases. Today, most risks from biological hazards can be reduced through the use of appropriate procedures and techniques, containment devices and facilities, and the training of personnel.
Literatur
1.
Zurück zum Zitat Pike RM (1976) Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci 13:105–114PubMed Pike RM (1976) Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci 13:105–114PubMed
2.
Zurück zum Zitat Harding LH, Byers KB (2006) Epidemiology of laboratory-acquired infections. In: Fleming DO, Hunt DL (eds) Biological safety: principles and practices, 4th edn. ASM Press, Washington, DC Harding LH, Byers KB (2006) Epidemiology of laboratory-acquired infections. In: Fleming DO, Hunt DL (eds) Biological safety: principles and practices, 4th edn. ASM Press, Washington, DC
3.
Zurück zum Zitat Henkel RD, Miller T, Weyant RS (2012) Monitoring select agent theft, loss and release reports in the United States—2004–2010. Appl Biosafety 17:171–180CrossRef Henkel RD, Miller T, Weyant RS (2012) Monitoring select agent theft, loss and release reports in the United States—2004–2010. Appl Biosafety 17:171–180CrossRef
4.
Zurück zum Zitat Mattar ZR, Abugiazya A, Torok N, Assaly R (2009) Laboratory-acquired coccodioidmycosis. Chest 136:28SCrossRef Mattar ZR, Abugiazya A, Torok N, Assaly R (2009) Laboratory-acquired coccodioidmycosis. Chest 136:28SCrossRef
5.
Zurück zum Zitat Kaye D (2005) Tularemia, laboratory acquired. Clin Infect Dis 40:3–4 Kaye D (2005) Tularemia, laboratory acquired. Clin Infect Dis 40:3–4
7.
Zurück zum Zitat Normile D (2004) Infectious diseases. Mounting lab accidents raise SARS fears. Science 304:659–661CrossRefPubMed Normile D (2004) Infectious diseases. Mounting lab accidents raise SARS fears. Science 304:659–661CrossRefPubMed
9.
Zurück zum Zitat Wurtz N, Grobusch MP, Raoult D (2014) Negative impact of laws regarding biosecurity and bioterrorism on real diseases. Clin Microbiol Infect 20:507–515CrossRefPubMed Wurtz N, Grobusch MP, Raoult D (2014) Negative impact of laws regarding biosecurity and bioterrorism on real diseases. Clin Microbiol Infect 20:507–515CrossRefPubMed
10.
Zurück zum Zitat Günther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST et al (2011) Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis 204:S785–S790 Günther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST et al (2011) Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis 204:S785–S790
14.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2011) Fatal laboratory-acquired infection with an attenuated Yersinia pestis strain—Chicago, Illinois, 2009. MMWR Morb Mortal Wkly Rep 60:201–205 Centers for Disease Control and Prevention (CDC) (2011) Fatal laboratory-acquired infection with an attenuated Yersinia pestis strain—Chicago, Illinois, 2009. MMWR Morb Mortal Wkly Rep 60:201–205
15.
Zurück zum Zitat Barry M, Russi M, Armstrong L, Geller D, Tesh R, Dembry L et al (1995) Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med 333:294–296CrossRefPubMed Barry M, Russi M, Armstrong L, Geller D, Tesh R, Dembry L et al (1995) Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med 333:294–296CrossRefPubMed
16.
Zurück zum Zitat Vasconcelos PF, Travassos da Rosa AP, Rodrigues SG, Tesh R, Travassos da Rosa JF, Travassos da Rosa ES (1993) Laboratory-acquired human infection with SP H 114202 virus (Arenavirus: Arenaviridae family): clinical and laboratory aspects. Rev Inst Med Trop Sao Paulo 35:521–525PubMed Vasconcelos PF, Travassos da Rosa AP, Rodrigues SG, Tesh R, Travassos da Rosa JF, Travassos da Rosa ES (1993) Laboratory-acquired human infection with SP H 114202 virus (Arenavirus: Arenaviridae family): clinical and laboratory aspects. Rev Inst Med Trop Sao Paulo 35:521–525PubMed
17.
Zurück zum Zitat Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, Widmer A (1999) Human infection due to Ebola virus, subtype Côte d’Ivoire: clinical and biologic presentation. J Infect Dis 179:S48–S53CrossRefPubMed Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, Widmer A (1999) Human infection due to Ebola virus, subtype Côte d’Ivoire: clinical and biologic presentation. J Infect Dis 179:S48–S53CrossRefPubMed
19.
Zurück zum Zitat Beer B, Kurth R, Bukreyev A (1999) Characteristics of Filoviridae: Marburg and Ebola viruses. Naturwissenschaften 86:8–17CrossRefPubMed Beer B, Kurth R, Bukreyev A (1999) Characteristics of Filoviridae: Marburg and Ebola viruses. Naturwissenschaften 86:8–17CrossRefPubMed
20.
Zurück zum Zitat Nikiforov VV, Turovskiĭ I, Kalinin PP, Akinfeeva LA, Katkova LR, Barmin VS et al (1994) A case of a laboratory infection with Marburg fever. Zh Mikrobiol Epidemiol Immunobiol 3:104–106PubMed Nikiforov VV, Turovskiĭ I, Kalinin PP, Akinfeeva LA, Katkova LR, Barmin VS et al (1994) A case of a laboratory infection with Marburg fever. Zh Mikrobiol Epidemiol Immunobiol 3:104–106PubMed
21.
Zurück zum Zitat Normile D (2004) Infectious diseases. Second lab accident fuels fears about SARS. Science 303:26CrossRefPubMed Normile D (2004) Infectious diseases. Second lab accident fuels fears about SARS. Science 303:26CrossRefPubMed
22.
Zurück zum Zitat Orellana C (2004) Laboratory-acquired SARS raises worries on biosafety. Lancet Infect Dis 4:64CrossRefPubMed Orellana C (2004) Laboratory-acquired SARS raises worries on biosafety. Lancet Infect Dis 4:64CrossRefPubMed
23.
Zurück zum Zitat Lim PL, Kurup A, Gopalakrishna G, Chan KP, Wong CW, Ng LC et al (2004) Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 350:1740–1745CrossRefPubMed Lim PL, Kurup A, Gopalakrishna G, Chan KP, Wong CW, Ng LC et al (2004) Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 350:1740–1745CrossRefPubMed
24.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2002) Suspected cutaneous anthrax in a laboratory worker—Texas, 2002. JAMA 287:2356–2358 Centers for Disease Control and Prevention (CDC) (2002) Suspected cutaneous anthrax in a laboratory worker—Texas, 2002. JAMA 287:2356–2358
25.
Zurück zum Zitat Traxler RM, Lehman MW, Bosserman EA, Guerra MA, Smith TL (2013) A literature review of laboratory-acquired brucellosis. J Clin Microbiol 51:3055–3062CrossRefPubMedPubMedCentral Traxler RM, Lehman MW, Bosserman EA, Guerra MA, Smith TL (2013) A literature review of laboratory-acquired brucellosis. J Clin Microbiol 51:3055–3062CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2000) Laboratory-acquired human glanders—Maryland, May 2000. MMWR Morb Mortal Wkly Rep 49:532–535 Centers for Disease Control and Prevention (CDC) (2000) Laboratory-acquired human glanders—Maryland, May 2000. MMWR Morb Mortal Wkly Rep 49:532–535
27.
Zurück zum Zitat Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, Spacek L et al (2001) Glanders in a military research microbiologist. N Engl J Med 345:256–258CrossRefPubMed Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, Spacek L et al (2001) Glanders in a military research microbiologist. N Engl J Med 345:256–258CrossRefPubMed
28.
Zurück zum Zitat Schlech WF 3rd, Turchik JB, Westlake RE Jr, Klein GC, Band JD, Weaver RE (1981) Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 305:1133–1135CrossRefPubMed Schlech WF 3rd, Turchik JB, Westlake RE Jr, Klein GC, Band JD, Weaver RE (1981) Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 305:1133–1135CrossRefPubMed
29.
Zurück zum Zitat Janovská S, Pávková I, Reichelová M, Hubáleka M, Stulík J, Macela A (2007) Proteomic analysis of antibody response in a case of laboratory-acquired infection with Francisella tularensis subsp. tularensis. Folia Microbiol (Praha) 52:194–198CrossRef Janovská S, Pávková I, Reichelová M, Hubáleka M, Stulík J, Macela A (2007) Proteomic analysis of antibody response in a case of laboratory-acquired infection with Francisella tularensis subsp. tularensis. Folia Microbiol (Praha) 52:194–198CrossRef
30.
Zurück zum Zitat Barry MA (2005) Report of pneumonic tularemia in three Boston University researchers. Boston Public Health Commission Barry MA (2005) Report of pneumonic tularemia in three Boston University researchers. Boston Public Health Commission
31.
Zurück zum Zitat Lam ST, Sammons-Jackson W, Sherwood J, Ressner R (2012) Laboratory-acquired tularemia successfully treated with ciprofloxacin: a case report. Infect Dis Clin Pract 20:204–207CrossRef Lam ST, Sammons-Jackson W, Sherwood J, Ressner R (2012) Laboratory-acquired tularemia successfully treated with ciprofloxacin: a case report. Infect Dis Clin Pract 20:204–207CrossRef
32.
Zurück zum Zitat Kawamata J, Yamanouchi T, Dohmae K, Miyamoto H, Takahaski M, Yamanishi K et al (1987) Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. Lab Anim Sci 37:431–436PubMed Kawamata J, Yamanouchi T, Dohmae K, Miyamoto H, Takahaski M, Yamanishi K et al (1987) Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. Lab Anim Sci 37:431–436PubMed
33.
Zurück zum Zitat Nielsen CF, Sethi V, Petroll AE, Kazmierczak J, Erickson BR, Nichol ST et al (2010) Seoul virus infection in a Wisconsin patient with recent travel to China, March 2009: first documented case in the Midwestern United States. Am J Trop Med Hyg 83:1266–1268CrossRefPubMedPubMedCentral Nielsen CF, Sethi V, Petroll AE, Kazmierczak J, Erickson BR, Nichol ST et al (2010) Seoul virus infection in a Wisconsin patient with recent travel to China, March 2009: first documented case in the Midwestern United States. Am J Trop Med Hyg 83:1266–1268CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Mulders MN, Reimerink JH, Koopmans MP, van Loon AM, van der Avoort HG (1997) Genetic analysis of wild-type poliovirus importation into The Netherlands (1979–1995). J Infect Dis 176:617–624CrossRefPubMed Mulders MN, Reimerink JH, Koopmans MP, van Loon AM, van der Avoort HG (1997) Genetic analysis of wild-type poliovirus importation into The Netherlands (1979–1995). J Infect Dis 176:617–624CrossRefPubMed
36.
Zurück zum Zitat Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E et al (2002) Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287:2236–2252CrossRefPubMed Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E et al (2002) Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287:2236–2252CrossRefPubMed
38.
Zurück zum Zitat Bhattacharjee Y (2011) Anthrax investigation. Army missed warning signs about alleged anthrax mailer. Science 332:27CrossRefPubMed Bhattacharjee Y (2011) Anthrax investigation. Army missed warning signs about alleged anthrax mailer. Science 332:27CrossRefPubMed
Metadaten
Titel
Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories
verfasst von
N. Wurtz
A. Papa
M. Hukic
A. Di Caro
I. Leparc-Goffart
E. Leroy
M. P. Landini
Z. Sekeyova
J. S. Dumler
D. Bădescu
N. Busquets
A. Calistri
C. Parolin
G. Palù
I. Christova
M. Maurin
B. La Scola
D. Raoult
Publikationsdatum
27.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 8/2016
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2657-1

Weitere Artikel der Ausgabe 8/2016

European Journal of Clinical Microbiology & Infectious Diseases 8/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.